Herbal Medicines Journal
No Article Processing Charges (APCs)

Effects of Satureja khuzestanica jamzad Supplementation on Inflammatory and Antioxidant Indicators in Type 2 Diabetes Patients: A Randomized Controlled Clinical Trial (RCT)

Document Type : Original Article

Authors

Sajjad Roosta 1
Maryam Bordbar 1
Yaser Mokhayeri 2
Fatemeh Ghasemi 1
Saeed Choobkar 3
Hamidreza Nikbakht 4
Ebrahim Falahi 5

1 Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran

2 Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran

3 School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

4 Boyerahmad Health center, Yasuj University of Medical Sciences, Yasuj, Iran

5 Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran

https://doi.org/10.22087/hmj.2025.231633
Abstract
Background and Aim: As the most common metabolic disorder, type 2 diabetes mellitus is growing exponentially worldwide. Satureja khuzestanica (SK) is a native plant of Iran that grows widely in southern Iran. Various animal studies have reported its antimicrobial, antioxidant, anti-inflammatory, and pain-relieving effects to date. The present research aimed to investigate the impact of the daily consumption of SK on inflammatory (IL-6, CRP) and antioxidant indicators (catalase, glutathione peroxidase, glutathione reductase, superoxide dismutase and total antioxidant capacity) in type 2 diabetic patients.
Materials and Methods: In a double-blind, placebo-controlled clinical trial, 78 patients (44 females and 34 male) with type 2 diabetes were included and randomly divided into two groups. One group received SK (capsule containing 500 mg) and the other group received placebo (500 mg talcum powder) once a day for 12 weeks. After the intervention, inflammatory and antioxidant indicators of the two groups were compared.
Results: The levels of total antioxidant capacity, superoxide dismutase, catalase, glutathione reductase, and glutathione peroxidase were remarkably distinct between the intervention and placebo groups, and these antioxidant indices were higher in the intervention group (P<0.05). Moreover, a considerable decrease in weight, CRP and IL-6 levels were observed in patients in the S. khuzestanica group.
Conclusion: As the findings of the study revealed, SK supplementation might improve the antioxidant and inflammatory indices of patients with T2DM. The results of this study could potentially offer new additional therapies for diabetes complications with no adverse side effects. These results should be further confirmed in clinical trials.

Keywords

Satureja khuzestanica
Diabetes mellitus
Antioxidant indicators
Il-6
C-reactive protein
  1. Hulse G K, English D R, Milne E, Holman CD. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94(2):221-9.
  2. Bailey CP, Connor M. Opioids: cellular mechanisms of tolerance and physical dependence. Current Opinion in Pharmacology. 2005;5:60-8.
  3. O’Connor PG. Methods of detoxification and their role in treating patients with opioid dependence. Journal of the American Medical Association. 2005; 294:961-3.

4.Espejo EF, Serrano MI, Caillé S, Stinus L.Behavioral expression of opiate withdrawal is altered after prefrontocortical dopamine depletion in rats: monoaminergic correlates. Neuropsychopharmacology. 2011;25(2):204-12.

  1. Harris GC, Aston-Jones G. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology. 1993; 9(4):303-11.
  2. Rasmussen K, Krystal JH, Aghajanian GK. Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology (Berl). 1991;105(4):508-12.
  3. Hack SP, Vaughan CW, Christie MJ. Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology. 2003;45(5):575-84.
  4. Abbasi-Maleki F, Abbasi-Maleki S, Mousavi SZ, Khayatnouri MH.Effect of hydroalcoholic extract of Avena sativa L. on morphine withdrawal signs in male mice. Quarterly Journal of Sabzevar University of Medical Sciences. 2014;20(4):408-15.
  5. Abbasi-Maleki N, Abbasi-MalekiS, Bekhradi R. Suppressive Effects of Rosa Damascena Essential Oil on Naloxone- Precipitated Morphine Withdrawal Signs in Male Mice.Iranian Journal of Pharmaceutical Research. 2013;12(3): 357-61.
  6. Abbasi Maleki S. Effect of ethanolic extract of Safflower on naloxone-induced morphine withdrawal signs in mice. Adv Herb Med. 2015;1(4):9-15.
  7. Godarzi M, Abbasi Maleki S, Mousavi S Z, Moradi Kor N. Morphine withdrawal symptoms improvement by Ziziphora tenuior L. ethanoic extract in male mice. Koomesh. 2016;17(4):990-5.
  8. Shirzadi D, Abbasi-Maleki S, Zanbouri A. Ethanolic extract of anise (Pimpinella anisum L.) attenuates morphine physical dependence in mice. J Herbmed Pharmacol. 2017;6(2):69-73.
  9. Abdel-Zaher AO, Abdel-Rahman MS FM EL. Blockade of nitric oxide overproduction and oxidative stress byNigella sativa oil attenuates morphine-induced tolerance and dependence in mice. Neurochem Res. 2010;35(10):1557-65.
  10. Raghavendra V, Rutkowski MD, DeLeo JA. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and shamoperated rats. Journal of Neuroscience. 2002;22:9980-89.
  11. Burkill IH. The useful plants of West Tropical Africa, Royal Botanic Garden, 1996;2:29-30.
  12. Santin MR, Dos Santos AO, Nakamura, CV, Filh BPD, Ferreira ICP, Ueda-Nakamura T. In vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis. Parasitology Reserch Journal. 2009;105:1489-96.
  13. Mirghani MES, LiyanaY, Parveen J. Bioactivity analysis of lemongrass (Cymbopogan citratus) essential oil. International Food Research Journal. 2012;19:569-75.
  14. Mannelli P, Patkar A,  Rozen S,  Matson W,  Krishnan R,  Kaddurah-Daouk R. Opioid use affects antioxidant activity and purine metabolism: preliminary results. Human Psychopharmacolgy. 2009;24(8):666-75.
  15. Uzama D. Phytochemical screening and antibacterial activity of garlic (Allium sativum L.) extracts. Environmental Science Journal Tropical. 2009;6(4):158-61.
  16. Zarrindast MR, Malekzadeh A, Rezayat M, Ghazi-Khansari M. Effects of cholecytokinin receptor agonist and antagonists on morphine dependence in mice.Basic and Clinical Pharmacolgy and Toxicology. 1995;77:360-4.
  17. Ghannadi A, Hajhashemi V, Abrishami R. Effects of the Persian Carum copticum fruit extracts on morphine withdrawal syndrome in mice. Research in Pharmaceutical Sciences. 2012;7(3):127-131.
  18. Sepu lveda J, Astorga JG, Contreras, E. Riluzole decreases the abstinence syndrome and physical dependence in morphine dependent mice. European Journal of Pharmacology. 1999;379:59-62.
  19. Caille S, Espejo EF, Reneric JP, Cador M, Koob, GF, Stinus L. Total neurochemical lesion of noradrenergic neurons of the locus coeruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. Journal of Pharmacology and Experimental Therapeutics. 1999;290:881-92.
  20. Viana GSB, Vale TG, Pinho RSN, Matos FJA. Antinociceptive effect of the essential oil from Cymbopogon citratus in mice.Journal of Ethnopharmacology.2000; 70(3):323-7.
  21. Blanco MM, Costa CARA, Freire AO, Santos JG Jr, Costa M. Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine.2009;16 : 265-70.
  22. Shah G, Shri R, Panchal V, Sharma N, Singh B, Mann AS. Scientific basis for the therapeutic use of Cymbopogon citratus,staff (Lemongrass). Journal of advanced pharmaceutical technology and research. 2011;2(1):3-8.
  23. Tangpu V, Yadav AK. Antidiarrhoeal activity of Cymbopogon citrates and its main constituent, citral. Pharmacologyonline. 2006;2:290-8.

 28.Costa CA, Kohn DO, de Lima VM, Gargano AC, Florio JC, Costa M.(2011). The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass). Journal of Ethnopharmacology. 2011;137:828-36.

29.Silva MR, Ximenes RM, da Costa JG, Leal LK, de Lopes AA, Viana GS.Comparative anticonvulsant activities of the essential oils (EOs) from Cymbopogon winterianus Jowitt and Cymbopogon citratus (DC) Stapf. in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 2011;381(5):415-26.

  1. Jitka S, Zdenka D, Jiri N. Morphine as a Potential Oxidative Stress-Causing Agent. Mini -Reviews in Organic Chemistry. 2013;10:367-72.
  2. Toda N, Kishioka S, Hatano Y, Toda H. Modulation of opioid actions by nitric oxide signaling. Anesthesiology. 2009;110(1):166-81.
  3. Cappendijk SL, Duval SY, de Vries R, Dzoljic MR: Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats. Neuroscience Letters. 1995;183:67-70.
  4. Figueirinha A, Paranhos A, Perez-Alonso JJ, Santos-Buelga C, Batista MT. Cymbopogon citratus leaves: Characterisation of flavonoids by HPLC–PDA–ESI/MS/MS and an approach to their potential as a source of bioactive polyphenols. Food Chemistry. 2008;110:718-28.
  5. Hutchinson MR, Lewis S, Coats B, Skyba D, Crysdale N, Berkelhammer D, Brzeski A. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain, Behavior, and Immunity. 2009;23:240-50.
  6. Francisco V, Figueirinha A, Neves BM, Garcia-Rodríguez C, Lopes MC, Cruz MT, Batista MT. Cymbopogon citratus as source of new and safe anti-inflammatory drugs: bio-guided assay using lipopolysaccharide-stimulated macrophages. Journal of Ethnopharmacology. 2011;133:818-27.
  7. Quintans-Junior LJ, Guimaraes AG, Santana MT, Araujo BES, Moreira FV, Bonjardim LR, et al.Citral reduces nociceptive and inflammatory response in rodents. Brazilian Journal of Pharmacognosy. 2011;21:497-502.
  8. Tiwari M, Dwivedi UN, Kakkar P.Suppression of oxidative stress and pro-inflammatory mediators by Cymbopogon citratus D. Stapf extract in lipopolysaccharide stimulated murine alveolar macrophages. Food and Chemical Toxicology. 2010;48:2913-9.

Guide for Authors

Submit Manuscript

Reviewers

Payments